SaidhaSGreenAJLeocaniL, et al. The use of optical coherence tomography and visual evoked potentials in the 2024 McDonald diagnostic criteria for multiple sclerosis. Lancet Neurol2025; 24(10): 880–892.
2.
BolloLParetoDTaglianiP, et al. Optic nerve imaging with OCT predicts disease progression and monitors brain and spinal atrophy in primary progressive multiple sclerosis. Mult Scler2026; 32(3): 279–288.
3.
SaidhaSSotirchosESOhJ, et al. Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol2013; 70(1): 34–43.
4.
BaileySTVemulakondaGAKimSJ, et al. Idiopathic epiretinal membrane and vitreomacular traction preferred practice pattern(R). Ophthalmology2025; 132(4): P197–P233.
5.
LinT-YBacchettiAMcCormackB, et al. Association of epiretinal membranes with disability in people with multiple sclerosis. Mult Scler J. Epub ahead of print 2026. DOI: 10.1177/13524585251312345.
6.
TewariePBalkLCostelloF, et al. The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS ONE2012; 7(4): e34823.
7.
RüferFBartschJJErbC, et al. Epiretinal membrane as a source of errors during the measurement of peripapillary nerve fibre thickness using spectral-domain optical coherence tomography (SD-OCT). Graefes Arch Clin Exp Ophthalmol2016; 254(10): 2017–2023.
8.
AsraniSEssaidLAlderBD, et al. Artifacts in spectral-domain optical coherence tomography measurements in glaucoma. JAMA Ophthalmol2014; 132(4): 396–402.
9.
LeeHJKimMSJoYJ, et al. Thickness of the macula, retinal nerve fiber layer, and ganglion cell layer in the epiretinal membrane: The repeatability study of optical coherence tomography. Invest Ophthalmol Vis Sci2015; 56(8): 4554–4559.
